A detailed history of Burkett Financial Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Burkett Financial Services, LLC holds 368 shares of LLY stock, worth $282,535. This represents 0.13% of its overall portfolio holdings.

Number of Shares
368
Previous 367 0.27%
Holding current value
$282,535
Previous $333 Million 2.05%
% of portfolio
0.13%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$772.14 - $960.02 $772 - $960
1 Added 0.27%
368 $326 Million
Q2 2024

Jul 10, 2024

SELL
$724.87 - $909.04 $28,269 - $35,452
-39 Reduced 9.61%
367 $333 Million
Q1 2024

Apr 01, 2024

BUY
$592.2 - $792.28 $9,475 - $12,676
16 Added 4.1%
406 $316 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $204,824 - $241,460
390 New
390 $227 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Burkett Financial Services, LLC Portfolio

Follow Burkett Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burkett Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burkett Financial Services, LLC with notifications on news.